Endocrine/exocrine intermediate cells in streptozotocin-treated ins- IFN-γ transgenic mice

Pancreas

Volumn 15, Issue 3, 1997, Pages 246-250

  Gu, Danling ^a   Arnush, Marc ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Diabetes; Endocrine exocrine intermediate cell; Ins IFN transgenie mice; Regeneration; Streptozotocin; cells

Indexed keywords

GAMMA INTERFERON; GLUCOSE; STREPTOZOCIN;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL REGENERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DEGRANULATION; ENDOCRINE CELL; EXOCRINE CELL; MOUSE; NONHUMAN; PANCREAS DUCT; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0030782731     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199710000-00005     Document Type: Article

References (20)

1. Gu DL, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 1993;118:33-46.
2. Gu DL, Lee MS, Krahl T, Sarvetnick N. Transitional cells in the regenerating pancreas. Development 1994;120(7):1873-81.
3. Herr RR, Jahnke HK, Argoudelis AD. The structure of streptozotocin. J Am Chem Soc 1967;89(18):4808-9.
4. Steiner H, Oelz O, Zahnd G, Froesch ER. Studies on islet cell regeneration, hyperplasia and intrainsular cellular interrelations in long lasting streptozotocin diabetes in rats. Diabetologia 1970;6: 558-64.
5. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976;193(4251):415-7.
6. Like AA, Appel MC, Williams RM, Rossini AA. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab Invest 1978;38(4):470-86.
7. Wilson GL, Leiter EH. Streptozotocin interaction with pancreatic β cells and the induction of insulin-dependent diabetes. Curr Topics Microbiol Immunol 1990;156:27-54.
8. Mosci P, Vecchiarelli A, Cenci E, Puliti M, Bistoni F. Low-dose streptozotocin-induced diabetes in mice. I. Course of Candida albicans infection. Cell Immunol 1993;150(1):27-35.
9. Gu DL, Arnush M, Sawyer SP, Sarvetnick N. Transgenic mice expressing IFN-gamma in pancreatic beta-cells are resistant to streptozotocin-induced diabetes. Am J Physiol 1995;269(6, Pt 1):E1089-94.
10. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 988;52: 773-82.
11. Sarvetnick N, Shizuru J, Liggitt D, et al. Loss of pancreatic islet induced by β-cell expression of Interferon-γ. Nature 1990;346: 844-7.
12. Melmed RN, Benitez CJ, Holt SJ. Intermediate cells of the pancreas 1. Ultrastructural characterization. J Cell Sci 1972;11:449-75.
13. Melmed RN. Intermediate cells of the pancreas. An appraisal. Progr Gastroenterol 1979;76:196-201.
14. Pour PM. Pancreatic centroacinar cells. The regulator of both exocrine and endocrine function. Int J Pancreatol 1994;5(1):51-64.
15. Bonner-Weir S, Trent DF, Honey R, Weir GC. Responses of neonatal rat islets to streptozotocin. Limited B-cell regeneration and hyperglycemia. Diabetes 1981;30:64-9.
16. Kern H, Logothetopolous J. Steroid diabetes in the guinea pig studies on islet-cell ultrastructure and regeneration. Diabetes 1970; 19:145-54.
17. Rosenberg L, Vinik AI. Induction of endocrine cell differentiation: a new approach to management of diabetes. J Lab Clin Med 1989; 114:75-83.
18. Lazarus SS, Shapiro SH. Streptozotocin-induced diabetes and islet cell alterations in rabbits. Diabetes 1972;21(3):129-37.
19. Lazarus SS, Shapiro SH. Serial morphologic changes in rabbit pancreatic islet cells after streptozotocin. Lab Invest 1972;27(2): 174-83.
20. Lazarus SS, Shapiro SH. Comparison of morphologic changes in nuclei of rabbit pancreatic islet β-cells induced by streptozotocin, alloxan, and in vitro necrosis. Lab Invest 1973;29(1):90-8.